Functionalized Carbon Nanotubes in the Brain: Cellular Internalization and Neuroinflammatory Responses by Bardi, G et al.
Functionalized Carbon Nanotubes in the Brain: Cellular
Internalization and Neuroinflammatory Responses
Giuseppe Bardi
1., Antonio Nunes
2.¤a, Lisa Gherardini
1.¤b, Katie Bates
2, Khuloud T. Al-Jamal
2¤c,
Claire Gaillard
3¤d, Maurizio Prato
4, Alberto Bianco
3, Tommaso Pizzorusso
1,5*, Kostas Kostarelos
2*
1CNR Neuroscience Institute, Pisa Area della recerca, Pisa, Italy and Center for MicroBioRobotics, ; IIT@SSSA, Pontedera, Pisa, Italy, 2Nanomedicine Laboratory, UCL School
of Pharmacy, University College London, London, United Kingdom, 3CNRS, Institut de Biologie Mole ´culaire et Cellulaire, UPR 9021 Immunologie et Chimie
The ´rapeutiques, Strasbourg, France, 4Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy, 5Department of Psychology, University of
Florence, Area San Salvi, Florence, Italy
Abstract
The potential use of functionalized carbon nanotubes (f-CNTs) for drug and gene delivery to the central nervous system
(CNS) and as neural substrates makes the understanding of their in vivo interactions with the neural tissue essential. The aim
of this study was to investigate the interactions between chemically functionalized multi-walled carbon nanotubes (f-
MWNTs) and the neural tissue following cortical stereotactic administration. Two different f-MWNT constructs were used in
these studies: shortened (by oxidation) amino-functionalized MWNT (oxMWNT-NH3
+) and amino-functionalized MWNT
(MWNT-NH3
+). Parenchymal distribution of the stereotactically injected f-MWNTs was assessed by histological examination.
Both f-MWNT were uptaken by different types of neural tissue cells (microglia, astrocytes and neurons), however different
patterns of cellular internalization were observed between the nanotubes. Furthermore, immunohistochemical staining for
specific markers of glial cell activation (GFAP and CD11b) was performed and secretion of inflammatory cytokines was
investigated using real-time PCR (qRT-PCR). Injections of both f-MWNT constructs led to a local and transient induction of
inflammatory cytokines at early time points. Oxidation of nanotubes seemed to induce significant levels of GFAP and CD11b
over-expression in areas peripheral to the f-MWNT injection site. These results highlight the importance of nanotube
functionalization on their interaction with brain tissue that is deemed critical for the development nanotube-based vector
systems for CNS applications.
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Introduction
Stereotactic surgery is a clinically used strategy for the delivery
of therapeutic agents into the brain. Despite the invasive nature of
the methodology, it allows precise and direct access to specific
areas within the brain [1], thus offering a realistic intervention for
the treatment of neurological diseases, such as Parkinson’s disease
[2] and Huntington’s disease [3,4]. The unique properties of
carbon nanotubes (CNTs) make them promising candidates for
the design of tools for interventions of the CNS. During the last
decade various studies have been published regarding the
utilization of nanotube electrical conductivity, mechanical resil-
ience and morphological similarity to neurites, for neurological
applications [5,6]. Previous studies employing various neuronal
cell culture models have explored the potential use of CNTs as
substrates for neuronal growth, taking advantage of their capacity
to integrate with neurons and enhance neuronal functions, such as
increased neurite outgrowth and branching [7–10]. f-CNTs have
also been shown to promote the re-establishment of synaptic
connections among neuronal populations. From a different
perspective, pre-clinical in vivo studies have also demonstrated that
f-CNTs can contribute to therapeutic strategies against CNS-
related disorders with complex pathological aetiologies, such as
stroke [11,12], spinal cord injury [13]and glioblastoma [14].
In view of this potential in neurological applications, it is
paramount to understand the interactions between CNT and
neural tissue cells in vivo. We have previously demonstrated the
feasibility of stereotactic administration of MWNTs injected
directly into the rodent cortex [15]and have also reported the
occurrence of nanotube degradative processes taking place [16].
Others have shown that intratumoral injections of CNTs (pristine
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conjugated with polyethylene glycol) using an intracranial
glioblastoma model were well-tolerated, eliciting only transient
and self-limiting local inflammatory responses [14]. Nevertheless,
knowledge regarding the CNT-neural cell interactions in vivo and
the CNT fate following cellular internalization within the CNS is
limited and requires further investigation.
Previous studies from our laboratories had illustrated that
amino-functionalized CNT complexed with siRNA were able to
lead to functional rehabilitation in an induced stroke model after
stereotactic administration [11]. In this study, we set out to
interrogate the interactions between these particular f-MWNTs in
comparison to their carboxylated iterations (that result in shorter
nanotubes) with brain tissue in vivo. The present study was
particularly designed to elucidate further the possible structure-
function relationship between f-MWNT surface functionalization
strategy and the resultant patterns of cellular internalization and
responses. Parenchymal distribution and the intracellular locali-
zation of f-MWNTs were assessed by histological examination and
transmission electron microscopy (TEM) two days and two weeks
following stereotactic injection. Furthermore, the inflammatory
response of the neighbouring neural tissue to the presence of f-
MWNTs was examined, in particular regarding cytokine expres-
sion and glial cell activation. We report that the type of chemical
functionalization used to surface-modify the f-MWNTs led to
significant differences in nanotube localization and distribution
patterns within the brain parenchyma, along with distinct
differences in cellular uptake and inflammatory reactivity.
Methods
Materials
MWNT were purchased from Nanostructured and Amorphous
Materials Inc. (Houston, TX; Lot # 1240XH, 95%). Outer
average diameter was 20–30 nm, and length between 0.5–1 mm.
MWNT-NH3
+, oxMWNT-NH3
+ and oxMWNT-amide-NH3
+
were prepared and fully characterized as recently described
elsewhere [19]. Chemicals and solvents were obtained from
Sigma-Aldrich (USA) and were used as received. Vectashield
fluorescent mounting media was purchased from Vector Labora-
tories (USA). 400-mesh copper grids coated with formvar/carbon
support film for TEM were from Agar ScientificH (UK). EuthatalH
was from Rhone Merieux (UK). Rabbit polyclonal anti-glial
fibrillary acidic protein (GFAP) primary antibodies were pur-
chased from Dako (USA) and mouse monoclonal anti-CD11b
antibodies were bought from BD (USA). Goat anti-rabbit Alexa
488-conjugated goat anti-mouse-Alexa 568 from Molecular
Probes (USA). Real-time PCR primers were obtained from
Sigma-Aldrich (USA) and the RNA extraction kit; RNeasy Mini
Kit from Qiagen. All RT-PCR reagents; cDNA synthesis kit
(Biorad iScript cDNA synthesis kit) and the 16Fast SYBR Green
Master Mix were bought from Biorad.
TEM micrograph of f-MWNT aqueous dispersions
f-MWNT powder was hydrated in 5% dextrose solution at
1 mg/ml concentration, by bath-sonicating the dispersions for 15–
30 minutes. The sonicated f-MWNT dispersions (250 mg/ml) were
deposited on 400-mesh copper grids coated with formvar/carbon
support film (Agar ScientificH, UK) and allowed to dry at room
temperature before imaging under TEM (Philips CM10). The
images were captured with high-resolution digital camera coupled
to the microscope.
Ethics statement
All experiments were performed in compliance and with prior
approval from the United Kingdom Home Office (1989) and
Code of Practice for the housing and care of Animals used in
Scientific Procedures under a Home Office project license (PPL
80/2296), evaluated by the UCL School of Pharmacy Ethical
Review Committee and in agreement with protocols approved by
the Italian Ministry for Scientific Research.
Animal handling and experimentation
Six to eight-weeks old female C57/Bl6 were caged in groups of
4–7 with free access to food and water. A temperature of 19–22 uC
was maintained, with a relative humidity of 45–65%, and a 12 h
light/dark cycle.
Stereotactic administration of f-MWNT
C57B1/6 mice were anesthetized with AvertinH (0.5 mL/100 g)
and mounted on a stereotactic apparatus. Injections of up to 1 ml
volume were made at specific stereotactic locations in the motor
cortex (latero-lateral(x) +0.5 mm, dorso-ventral(y) +1.5 mm, ros-
tro-caudal(z) 0.7 mm) by means of a glass pipette (30 mm tip
diameter) mounted on a motorized (0.1 mm step) three-axis
micromanipulator connected to an injector (Sutter Instruments,
Novato, CA, USA). During injections, the animals were oxygen-
ated and heated using a blanket with a thermostat to ensure a
37uC rectal temperature. At the end of all surgical procedures, the
scalp incision was closed with Mersilk sutures (Ethicon, UK), and
the antibiotic gentamicin was topically administered to prevent
infections. In these conditions the whole procedure lasted around
20 min, and recovery from anaesthesia occurred after 60–90 min.
After recovery, the animals were returned to their home cages,
until they were culled at the desired time-point according to the
experimental schedule.
Tissue (brain) sections and transmission electron
microscopy
Mice (n=2–3) were transcardially perfused under terminal
anaesthesia (EuthatalH) with 3% glutaraldehyde in 0.5 M caco-
dylate buffer (pH 7.4). After perfusion, brains were removed,
immersed in the perfusate for 2–4 days at 4uC, allowing adequate
penetration of the primary fixative. The brains were then
transferred to 1 M cacodylate buffer until ready to be processed
(TEM or H&E histology). Specimens of 1 mm were cut using
brain matrices (Zivvic InstrumentsH, USA). Each specimen was
washed several times with deionised water, submitted to a second
fixation with osmium tetroxide (OsO4) for 90 min, rinsed with
deionised water, and then dehydrated by a series of ethanol
grades: 70%, 90%, and 100%. Specimens were infiltrated with
propylene oxide, followed by 1:1 (v/v) propylene oxide:araldite
resin and finally were left in neat resin overnight at room
temperature. Specimens were then placed at the desired orienta-
tion in the embedding moulds and placed in 60uC oven to allow
for resin polymerisation for 2–3 days. Semi-thin sections (approx-
imately 0.71 mm thickness) were obtained using an ultramicrotome
and SEMI diamond knife (SEMi, Leica, UK). The stained semi-
thin sections were stained with toluene blue, rinsed in distilled
water and mounted in a slide to be observed under light
microscope. TEM was performed on precisely aligned ultra-thin
section (approximately 70 nm thickness) obtained by an ultrami-
crotome and a diamond knife (Diatome 45u, Leica, UK). The
sections were collected onto 400 thin copper 3.05 mm grids
(Athene grids, Agar Scientific, UK) and observed unstained under
TEM (10–15 grids per animal were observed).
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For H&E staining (several slides were imaged per animal),
specimens of 1 mm were processed for routine histology by the
Laboratory Diagnostic Service of the Royal Veterinary College
(London, UK). H&E stained sections of 4 mm thickness were
observed and examined under light microscope.
Immunofluorescence (glia and microglia activation
studies)
Injected mice were transcardially perfused with ice-cold 4%
paraformaldehyde in 0.1 M TBS, pH 7.4. Brains were quickly
removed and cryoprotected in 30% sucrose overnight and then 50
mm coronal sections were cut on cryostat and processed for
immunofluorescence. To permeabilize cells and block non-specific
antibody binding, free-floating paraformaldehyde fixed 50 mm
slices were treated for 90 min at room temperature with 0.2%
Triton/phosphate buffered saline (PBS) solution (0.1 M) contain-
ing 10% fetal bovine serum (FBS). Rabbit polyclonal anti-Glial
Fibrillary Acidic Protein (GFAP) primary antibodies (1:500
dilution) and mouse monoclonal anti-CD11b (1:400 dilution) were
used overnight at 4uC in the 0.2% Triton/10% FBS/PBS
solution. The slices were then incubated with goat anti-rabbit
Alexa 488-conjugated (1:400 dilution) and goat anti-mouse-Alexa
568 (1:400 dilution) in 10% FBS/PBS solution at room
temperature for 2 hours. Slices were rinsed extensively in PBS
and mounted on glass slides with Vectashield, preparations were
cover slipped, sealed with nail polish, and scanned with a Leica
TCS-NT confocal microscope (Leica Microsystems) equipped with
an argon–krypton laser, at resolutions of 5126512 pixels at 106
magnification. A certain degree of activated glia markers was
present in the cells adherent to the injection, for all three types of f-
MWNTs and control. To quantify the fluorescence we excluded
the cells adherent to the injection site as a minimal level of
activation is always present by glial cells in contact with a non-self
recognized material, such as f-MWNTs. Image files were analyzed
off-line with MetaMorph (version 5.0r1 MetaMorph; Molecular
Devices) to measure fluorescence intensity in an area of 160.5 mm
surrounding the injection sites. To evaluate the statistical
significance of the results, the average 6 SEM of 6 slices/mice
was calculated and at least 3 mice per treatment were sacrificed in
three independent experiments. One-way statistical analysis of
variance followed by analysis with the Student-Newman-Keuls
method was performed.
In order to further quantify the fluorescence image files were re-
analyzed in an area of 160.5 mm surrounding the injection sites
with ImageJH software. Histograms of green (GFAP) or red
(CD11b) positive pixel were analyzed. We used the tool ImageJ/
Analyze/Histogram/List, followed by the sum of the counted
pixels. The positive pixels at lower intensity (5% of the total pixels)
were excluded in order to avoid background noise. To evaluate the
statistical significance of the results, the average 6 SEM of 6
slices/mice was calculated and at least 3 mice per treatment were
sacrificed in three independent experiments. One-way statistical
analysis of variance followed by analysis with the Bonferroni
method was performed.
Quantitative RT-PCR
After the stereotactic injection with 5% dextrose saline solution,
LPS positive control, MWNT-NH3
+ or oxMWNT-NH3
+ B57BL/
6 mice were sacrificed at the desired time-point (3, 16, 24 hours, 7
and 14 days) and the brains were quickly removed and
anatomically dissected. The right hemisphere of the cortex
(injection site) was cryopreserved ready for RNA extraction. Brain
tissue was homogenised using liquid nitrogen and total RNA was
extracted with an RNeasy Mini Kit according to the manufactur-
er’s instructions (Qiagen). The concentration of total RNA was
determined by measuring the optical density 260 nm/280 nm
ratio. RNA purity was confirmed between the expected values of
1.8–2.0. First strand cDNA was prepared from 1 mg RNA in a
total volume of 20 mL using the Biorad iScript cDNA Synthesis
Kit. Real-time-PCR was performed using the CFX96
TM Re-
alTime-PCR Detection System (BioRad). The reactions contained
16 Fast SYBRH Green Master Mix (Biorad), each primer at
200 nM (Please see Table S1 for further details) and 1 mLo f
cDNA from reverse transcription PCR in a 25 mL reaction. After
an initial denaturation step at 95 uC for 10 min, amplification was
carried out with 40 cycles of denaturation at 95uC for 10 sec,
annealing at 60 uC for 30 sec. Amplification was followed by a
melting curve analysis to confirm PCR product specificity. No
signals were detected in no-template controls. All samples were
run in triplicates and the mean value of each triplicate was used for
further calculations. Relative expression was calculated using the
2-DDCT method. The quantity of b-actin (housekeeping)
transcript in each sample was used to normalize the amount of
each primer transcript. Then the normalized values for each
primer transcript were compared to the normalized expression in
the 5% dextrose control groups to calculate a fold change value.
To evaluate the statistical significance of the results, the average
6 standard deviation (SD) of 4 mice per treatment group and per
time-point was calculated. One-way statistical analysis of variance
(One-way ANOVA) followed by post-hoc analysis with the
Bonferroni method was performed.
Results
Chemical functionalization and characterization of f-
MWNTs
In order to investigate the effect of chemically functionalized
MWNTs on the interactions with cortical brain tissue in vivo, two
different chemical strategies were used to functionalize the surface
of MWNTs: shortened (by oxidization) and amino-functionalized
(oxMWNT-NH3
+) and only amino-functionalized (MWNT-
NH3
+). MWNT-NH3
+ were functionalized by 1,3-dipolar cyclo-
addition of azomethine ylides, which we previously reported in
Georgakilas et al. [17] and had a length between 0.5–1mm.
oxMWNT-NH3
+ were synthesized following a 2-step protocol
consisting of: a) oxidation of pristine MWNTs, and b) introduction
of amine groups via 1,3-dipolar cycloaddition reaction, as already
reported in the literature [18]. Oxidation of the pristine MWNTs
in step (a) led to the introduction of carboxyl groups and the
shortening of the nanotubes, with lengths between 200–300 nm.
The molecular structures and TEM images of both f-MWNTs are
shown in Figure 1. TEM analysis indicated that both f-MWNTs
were individualized, with good aqueous dispersibility, and free
from any major impurities. The degree of amino group loading on
the f-MWNT surface was determined by the Kaiser test and was
comparable between both f-MWNT (147mmol/g for MWNT-
NH3
+ and 170 mmol/g for oxMWNT-NH3
+), while more
complete characterization data of the same material has been
recently published elsewhere [19].
In vivo brain parenchyma distribution after stereotactic
administration of f-MWNTs
f-MWNTs were stereotactically injected into the motor cortex
(latero-lateral(x) +0.5 mm, dorso-ventral(y) +1.5 mm, rostro-cau-
dal(z) 0.7 mm) as a single dose of 500 ng/mouse. Two days and
two weeks post-injection, brain tissue was extracted and the
Functionalized Carbon Nanotubes in the Brain
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+ and oxMWNT-NH3
+
were assessed by performing haematoxylin and eosin (H&E) and
by TEM. Histological examination of sequential coronal brain
sections at two days post-injection, indicated that both f-MWNT
constructs showed no major differences regarding their spatial
distribution in the brain parenchyma. Taking into account the
number of sequential sections and the thickness of each section, we
could observe that oxMWNT-NH3
+ was detected within 310–330
mm in comparison to MWNT-NH3
+ that was detected within 260–
270 mm thickness (data not shown). However, at two weeks post-
injection, the examination of sequential coronal sections (H&E
staining) showed different distribution patterns between MWNT-
NH3
+ and oxMWNT-NH3
+ in relation to the injection site
(Figure 2).
MWNT-NH3
+ were detected more abundantly distributed
throughout the injection site and within the brain parenchyma
in comparison to oxMWNT-NH3
+. MWNT-NH3
+ were identified
in several sequential coronal sections (120–140mm thick)
(Figure 2A, arrows), whereas oxMWNT-NH3
+ were only
observed in a much narrower area, a few sequential sections
between 30–50 mm thick (Figure 2B, arrows & Figure S1).
These spatial measurements took into account the dorso-ventral(y)
distance between the first coronal section that nanotubes were
visualized until the last coronal section where nanotubes could be
observed. Furthermore, MWNT-NH3
+ were not only observed
local to the injection site, but also seen in different regions of the
cortex, in particular close to ependymal cells (that form the
interface between the brain parenchyma and ventricles) and also
within the brain ventricles (Figure 2C & Figure S2).
Internalization of f-MWNT within neural tissue cells
following intracortical administration
To better understand the cellular internalization and intracel-
lular fate of f-MWNTs brain sections were processed and imaged
by TEM two days post-injection. Electron micrographs of brain
tissue confirmed that both types of f-MWNTs were internalized
within neural tissue cells in vivo (Figure 3). Interestingly, the two
f-MWNT types showed different patterns of intracellular distribu-
tion by TEM. Amino-functionalized alone MWNT-NH3
+ were
more evenly dispersed throughout the brain parenchyma and
within cells (Figure 3A). It was possible to observe repeatedly
MWNT-NH3
+ being internalized into cells and single, individu-
alized nanotubes piercing cellular membranes (Figure S3). Once
within the cell, MWNT-NH3
+ appeared either as small aggregates
enclosed within membranous intracellular vesicles or as individ-
ualized nanotubes residing in the cytoplasm (Figure 3C).
oxMWNT-NH3
+ on the other hand, despite being shorter than
MWNT-NH3
+ were always observed in clusters (Figure 3B),
predominantly uptaken by neuronal cells as clusters wrapped
within intracellular vesicles, presumably microglial phagosomes,
very rarely seen individualized in the cytoplasm (Figure 3D).
Cytokine-associated inflammatory response following
intracortical administration of f-MWNTs
The induction of inflammatory cytokines (see Table S1 for
further details of primers) in the cortex was then investigated
following stereotactic injection of 5% dextrose solution, lipopoly-
saccharide (LPS) used as positive control, MWNT-NH3
+ and
oxMWNT-NH3
+ (Figure 4A). All values are expressed as relative
levels of mRNA expression at the cortex (including the site of
injection) in relation to those following injection with dextrose.
LPS induced significant increases in the expression levels of all
pro-inflammatory cytokines, greatly exceeding the levels induced
by both f-MWNTs, peaking at 16 hr and subsiding by 24 hr. The
only anti-inflammatory cytokine that displayed a different profile
of expression was IL-10, showing elevated levels up to 7 days and
returning to baseline after 14 days. Overall, oxMWNT-NH3
+
consistently induced a higher expression of pro-inflammatory
cytokines in comparison to MWNT-NH3
+. At 16 hr post-
injection, statistical significance was observed between the two f-
MWNTs for the pro-inflammatory cytokines TNF-a and IL-1b.
To confirm that the increased expression of cytokines from the f-
MWNT injections was transient, we measured cytokine levels at 7
and 14 days. Notably, the increase seen in cortical cytokine
expression levels at earlier time points (maximum at 16 hr)
decreased to background levels for both f-MWNTs at the later
time-points (7 and 14 day). It is important to note that the transient
increase in pro-inflammatory cytokine expression levels for both f-
MWNTs were only 4-8 times higher than the dextrose injected
baseline levels, and significantly lower compared to LPS (20–30
times higher than dextrose saline-injected brain).
Astrocyte and microglia cell activation following
intracortical administration of f-MWNTs
To further explore the potential cellular reactivity by the
presence of f-MWNTs in the cortical parenchyma, we investigated
the in vivo activation of astrocytes and microglia by immunoflu-
orescence. Coronal brain tissue sections (50mm thickness) were
stained with the antibodies GFAP and CD11b, 3 and 30 days post-
stereotactic injection. Staining tissue sections for glial fibrillary
acidic protein (GFAP) aimed at the identification of activated
astrocytes, whereas the microglia/macrophage marker CD11b
overexpression was interpreted as a sign of active inflammation
[20]. Three days after injection, GFAP and CD11b staining of the
control group (5% dextrose saline) was similar to that observed for
both f-MWNTs injected groups (Figure S4 & Figure S5).
Interestingly, 30 days after stereotactic injection, immunohisto-
chemical analysis revealed that both astrocytes and microglia
activation was significantly different between the two types of f-
Figure 1. Structural features of f-MWNTs. A) Chemical structures
of f-MWNTs. B) TEM images of f-MWNTs dispersed in 5% dextrose at 250
mg/ml final concentration (scale bar 100 nm).
doi:10.1371/journal.pone.0080964.g001
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the histograms of green (GFAP) or red (CD11b) positive pixel in
the area around the injection site (160.5mm) indicated that the
oxMWNT-NH3
+ induced higher expression of GFAP and CD11b
(Figure 4B). In contrast, injection of MWNT-NH3
+ did not lead
to overexpression of astrocyte or microglia activation markers after
30 days post-administration. In order to investigate this phenom-
ena further, we used a third type of chemically functionalized
MWNTs that were initially oxidized and then further modified by
performing amidation of the carboxylic groups at the surface of
those nantoubes using triethylene diamine (oxMWNT-amide-
NH3
+)( Figure S6A). Similar to oxMWNT-NH3
+, stereotactic
injection of the aminated nanotubes oxMWNT-amide-NH3
+ also
led to upregulation of GFAP and CD11b positive cells suggesting
activation taking place (Figure 4B & Figure S6&C). It is known
and expected that not all carboxylic functions at the nanotube
surface can be transformed into ammonium groups. The
remaining unreacted –COOH groups at the surface of the
oxMWNT-amide-NH3
+ may indeed be provoking the observed
inflammatory response. However, further experiments should be
undertaken to elucidate such mechanisms in more detail.
Lastly, an observation that was consistent for all brain tissues
treated with both types of f-MWNTs that were initially oxidized
(oxMWNT-NH3
+ and oxMWNT-amide-NH3
+), but not with the
Figure 2. Parenchymal distribution of MWNT-NH3
+and oxMWNT-NH3
+ after stereotactic administration in the motor cortex of
C57BL/6 mice by light microscopy of H&E stained coronal sections, two weeks after injection with nanotubes. A) MWNT-NH3
+;B )
oxMWNT-NH3
+; C) High magnification images of the MWNT-NH3
+ injected tissue. Cortex (CX), ependymal layer (EL), and ventricles (VT) are noted,
respectively. The distance from the Bregma line for each section is indicated above each image. Black arrows indicate the presence of f-MWNTs in the
sections.
doi:10.1371/journal.pone.0080964.g002
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+), was the pres-
ence of mast cells in certain regions of the brain close to
perivascular space (Figure S7). Mast cells can be identified by
metachromatic stain in the presence of blue basic dyes (such as
toluidine blue staining) under light microscopy (Figure S7B). The
ultra-structure of mast cells was also confirmed by TEM
(Figure S7C). No such evidence of increased numbers of mast
cells within brain parenchyma was noted in groups treated with
5% dextrose or MWNT-NH3
+. Mast cells are an important
member of both the innate and acquired immune system, and
their function as effector cells in inflammatory responses underlie
immediate hypersensitivity reactions [21]. Under physiological
conditions mast cells are located in restricted areas of the brain
(mainly the thalamus and hypothalamus). However, recently it has
been shown in an in vitro model that mast cells can respond to
microglia activation due to cytokine and chemo-attractant release
[22].
Discussion
Even though conflicting data has been reported concerning the
safety of CNTs that can lead to confusion, it is important to
highlight that chemically functionalized MWNTs have consistently
provided a significantly improved safety profile compared to their
non-functionalized precursors [23,24]. Regarding the interactions
between CNTs and neural tissue cells in vivo, and their impact on
potential short- and long-term neurotoxicity, studies remain
scarce.
In this work, we attempted to vary the structure and surface
characteristics of the carbon nanotubes in order to comparative
investigate the relationship between carbon nanotube surface
functionalization and cellular reactivity, paying particular atten-
tion to the internalization of f-MWNTs, the intracellular fate and
the neuroinflammatory response in vivo after exposure to different
chemically functionalized nanotubes. One of the nanotubes
studied was prepared by the 1,3-dipolar cycloaddition reaction
on pristine and purified CNTs that yielded ammonium functio-
nalized MWNTs (MWNT-NH3
+) with a length of between 0.5–1
mm. This type of amino-functionalized nanotubes has been shown
to be effective in the delivery of siRNA sequences into solid tumors
[25]. More recently, we have reported their capability to deliver
siRNA in the rodent cortex and offer therapeutic activity in an
endothelin-induced stroke model leading to functional recovery of
the behaviour of the animals [11]. The second type of chemically
functionalised carbon nanotubes (oxMWNT-NH3
+) investigated in
this work also underwent amino-functionalization using the 1,3-
dipolar cycloaddition reaction, however the reaction was per-
formed on oxidized MWNTs. This oxidation step both shortened
these nanotubes and introduced carboxylic groups on their surface
and tips. Previous studies had demonstrated that such type of
carbon nanotube is highly biocompatible with neuronal cells in
vitro, without altering cell viability, neuronal morphology or
normal functions in primary neurons [18]. TEM confirmed that
both MWNT-NH3
+ and oxMWNT-NH3
+ exhibited adequate
aqueous dispersibility and individualization of the tubes that
allowed further biological investigations.
Histological examination of sequential coronal sections two
weeks after stereotactic injection of nanotubes in the murine cortex
revealed that MWNT-NH3
+ were more widely dispersed within
brain parenchyma in comparison to oxMWNT-NH3
+. The
internalization and intracellular fate of CNTs along with possible
neuroinflammatory responses are all of major importance,
especially in view of their potential use for the treatment of CNS
disorders. The ability of CNTs to internalize within neural cells in
vivo constitutes an advantageous property as their therapeutic
cargo may be directly delivered to the cytoplasm of cells and
therefore reach specific intracellular therapeutic targets. Internal-
ization of carbon nanotubes into microglia and neurons in vivo has
been suggested previously in literature [14,26]. In order to better
visualize the localization and intracellular fate of f-MWNTs, TEM
examination was performed in unstained sections two days after
stereotactic injection into the motor cortex. Results indicated that
both carbon nanotubes were taken up by a variety of neural tissue
cells (microglia and neurons), with evidence suggesting that
microglia were predominantly responsible for the observed cellular
uptake. This observation was in agreement with previous studies
Figure 3. Uptake of f-MWNTs by neural tissue cells in vivo.
Transmission electron micrographs (TEM) of brain parenchyma close to
the injection site: A) low magnification TEM following injection with
MWNT-NH3
+. It was also possible to observe individualized MWNT-NH3
+
at the extracellular spaces. B) low magnification TEM following injection
with oxMWNT-NH3
+ mainly localized intracellularly in clusters and
within vesicles. C) and D) show TEM images of increasing magnification
of a neural tissue cells containing MWNT-NH3
+ and oxMWNT-NH3
+
intracellularly. i( C&D )low magnification TEM of a neural cell
containing intracellular CNT. ii and iii (C&D) shows higher magnifi-
cation of the cytoplasm of the cell imaged on pannel i (C&D). iv shows
higher magnification of cytoplasm of cell imaged on panel i, being able
to identify the presence of more individualized CNT (iv C) or clusters
and within vesicle CNT (iv D).
doi:10.1371/journal.pone.0080964.g003
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PLOS ONE | www.plosone.org 7 November 2013 | Volume 8 | Issue 11 | e80964reporting intratumoral injection of nanotubes in an intracranial
glioblastoma model [14]. However, it is important to highlight that
in these models the brain tissue is already conditioned by the
implantation of the glioblastoma tumor cells, which per se affect
tissue architecture and the levels of microglia activation.
Once internalized, MWNT-NH3
+ were visualized either within
vesicles or as free individualized nanotubes in the cytoplasm. The
different intracellular localization sites seem to be related to the
prevailing mechanisms of uptake [27–28] suggesting a combina-
tion of endocytosis or phagocytosis of f-MWNT and direct
translocation of individualized nanotubes through the cellular
membrane. The simultaneous occurrence of internalization
pathways has been described in the literature previously using
other types of cells [29–31]. In agreement with such interpreta-
tions, we have recently reported data from two different studies
that used non-phagocytic A549 cells or primary human monocyte-
derived macrophages (HMMs), a proficient phagocytic cell type
[32,33]. Flow cytometry, confocal microscopy and TEM con-
firmed that cellular internalization of f-MWNT (MWNT-NH3
+
and oxMWNT-NH3
+) can occur simultaneously by multiple
internalization pathways [33], the predominant mechanism being
dependent on the cell type used (phagocytic or non-phagocytic), as
well as on the CNT surface functionalization and physicochemical
characteristics of the CNT dispersions. The results in the present
study suggest that direct membrane translocation of f-MWNT can
take place in vivo both by piercing the plasma membrane upon
nanotube entrance into cells or after vesicular internalisation by
piercing the vesicular membrane to escape into the cytoplasm. In
both cases, individualization of nanotubes is necessary to facilitate
this process. This has been illustrated in vivo in this study by
comparison of the two nanotube types. TEM showed that
MWNT-NH3
+ were mainly individualized and present in both
intracellular and extracellular domains, while oxMWNT-NH3
+
were mainly detected as small clusters and within intracellular
vesicles, with a very limited amount visualized individual (cluster-
free) in the extravesicular cytoplasmic or brain parenchymal areas.
Moreover, two weeks after injection oxMWNT-NH3
+ were hardly
detectable, suggesting a clearance mechanism in operation that
may well involve microglia activation. However, more work is
needed on this front to identify such mechanisms.
Any application that involves implantation or injection of
material directly into the brain needs to address the question of
inflammatory responses triggered following interaction with CNS
tissue. In this study, we observed that both f-MWNTs induce a
transient increase in almost all pro-inflammatory cytokines, yet at
significantly lower levels compared to the positive control (LPS).
Following injury, reactive gliosis occurs as a response by
endogenous glial cells, such reaction is sustained by the activation
of both astrocytes and microglia cells, which are key elements in
the process of brain inflammation [34,35]. Reactive gliosis has
been suggested as an early marker of damage within the brain, and
may be detected morphologically and quantified by measurements
of GFAP increase. Microglial cells are the resident immune
effectors of the CNS, with the ability to respond to the most subtle
neuronal injury [36,37]. Under certain conditions, microglia
become activated, changing to the characteristic macrophage
morphology. Following activation, microglia express different
proteins and surface markers, such as CD11b, which upon
activation is significantly up-regulated [36]. We found that the
injection of f-MWNT mainly elicited an expression of GFAP and
CD11b at the injection site, suggesting a self-limiting local
inflammatory response caused by injection of the material.
Furthermore, up to 30 days post-injection, only oxidized MWNTs
(oxMWNT-NH3
+ or oxMWNT-amide-NH3
+) led to sustained
levels of microglia and astrocyte activation at the area around the
injection site, implicating the role of carboxyl groups at the
nanotube surface. This was not observed in the brains injected
with 5% dextrose or MWNT-NH3
+, indicating an improved
profile for the latter.
In conclusion, oxMWNT-NH3
+ throughout this study led to
cytokine and glial cell activation, suggesting that oxidation of the
nanotube surface can contribute to a sustained inflammatory
reaction in healthy brain. On the other hand, MWNT-NH3
+ was
better tolerated, eliciting only a local and transience inflammatory
response, without major activation of glial cells and inflammatory
cytokines. The significance of these observations lies on the
previously unreported effort to identify the importance of
nanotube chemical functionalization on the neurotoxicity of
CNT after their interaction with neural cells in vivo. Overall, this
is deemed extremely important, in particular for the development
of both CNT-based delivery systems and implantable devices for
CNS applications.
Supporting Information
Figure S1 Brain distribution of oxMWNT2NH3+ after stereo-
tactic administration in the motor cortex of C57BL/6 mice by
light microscopy of H&E stained coronal sections, two weeks after
injection with nanotubes. Whole coronal section of the brain (top)
shows oxMWNT2NH3+ in the brain parenchyma. Middle and
bottom panels show high magnification images of the
oxMWNT2NH3+ detected in brain parenchyma. Cortex (CX),
and ventricles (VT) are noted, respectively. Black arrows indicate
the presence of f-MWNTs in the sections.
(TIF)
Figure S2 Brain distribution of MWNT2NH3+ after stereo-
tactic administration in the motor cortex of C57BL/6 mice by
light microscopy of H&E stained coronal sections, two weeks after
injection with nanotubes. Parenchymal (left), Ependymal Layer
(middle) and Lateral Ventricle (right) regions are shown, depicting
the presence of MWNT2NH3+ throughout these regions. Bottom
panels show high magnification images of the MWNT2NH3+
injected tissue. Cortex (CX), ependymal layer (EL), and ventricles
(VT) are noted, respectively. Black arrows indicate the presence of
f-MWNTs in the sections.
(TIF)
Figure 4. Neuroinflammatory response following intra-cortical injection of f-MWNTs. A) Panel of cytokine expression profiles in C57BL/6
mouse cortex following stereotactic injection of 5% dextrose solution, LPS, MWNT-NH3
+ and oxMWNT-NH3
+ (n=4 for each group). mRNA expression
levels were assessed using quantitative rtPCR. Relative gene expression was calculated using the 2-DDCT method. Relative gene expression levels
(plotted as fold increases) were calculated by first normalizing the values for each primer transcript against the house-keeping gene b-actin, and then
further normalized against the 5% dextrose control group, giving relative gene expression values (fold-change (mean 6 SD)). Both f-MWNTs caused a
transient increase in the pro-inflammatory cytokine expression levels, peaking at 16 hr. oxMWNT-NH3
+ induced significantly higher expression levels
of TNF-a and IL-1b at 16 hr compared to MWNT-NH3
+ (p,0.001). B) Glia activation studies 30 days after stereotactic injection with 5% dextrose saline
solution, MWNT-NH3
+, oxMWNT-amide-NH3
+ and oxMWNT-NH3
+ (n=3 for each group). Histograms of green (GFAP) or red (CD11b) positive pixel
were analysed. The positive pixels at lower intensity (5% of the total pixels) were excluded in order to avoid background noise.The intensity was
measured and quantified in an area 160.5 mm surrounding the injection site.
doi:10.1371/journal.pone.0080964.g004
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TEM 2 days post cortical administration. The extracellular
presence of MWNT2NH3+ in different brain areas (A and B) is
shown. It is possible to observe the engulfment process of the CNT
in bundles (arrows) or the direct translocation of individualized
CNT through the cellular membrane (arrow heads).
(TIF)
Figure S4 Glia activation studies after stereotactic injection. A)
& B) Show immunohistochemical staining of brain sections after
injection with 5% dextrose solution, MWNT2NH3+ and
oxMWNT2NH3+, 3 and 30 days post-injection respectively.
Green channel represents glial fibrillary acidic protein (GFAP)
positive cells (astrocyte marker) and the red channel represents
CD11b positive cells (microglia marker).
(TIF)
Figure S5 Glia activation studies after stereotactic injection with
5% dextrose saline solution, MWNT2NH3+ and
oxMWNT2NH3+ (n=3 for each group). Average fluorescence
intensity corresponding to total glia (GFAP) and microglia
(CD11b) activation after 3 and 30 days. The intensity was
measured and quantified in an area 160.5 mm surrounding the
injection site.
(TIF)
Figure S6 Effects from cortical injection with oxMWNT2ami-
de2NH3+. A) Chemical structure and TEM images of oxMWN-
T2amide2NH3+ dispersed in 5% dextrose at 250mg/ml final
concentration (scale bar 100 nm). C) & D) Glia activation studies
after stereotactic injection with oxMWNT2amid2NH3+.C )
Immunohistochemistry of brain sections at 3 and 30 days post-
administration. Green channel represents GFAP-positive cells
(total glia), red channel represents CD11b-positive cells (microglia).
D) Average fluorescence intensity induced by astrocyte activation
(GFAP) and by microglia activation (CD11b) after 3 and 30 days,
respectively. Intensity was measured and quantified in an area of
160.5 mm surrounding the injection sites.
(TIF)
Figure S7 H&E stained light microscopy images of brain
sections 14 days post-injections with: A) MWNT2NH3+ and B)
oxMWNT2NH3+. H&E staining shows no evidence of the
presence of mast cells after stereotactic injection of
MWNT2NH3+. Mast cells (arrows) could be visualized after
injection of oxMWNT2NH3+ (B and C); C) shows semi-thin
section of brain parenchyma 14 days post –injection with
oxMWNT2NH3+ stained with toluene blue. Ci) & Cii) represent
TEM of mast cells with their typical granules (G) present in the
cytoplasm.
(TIF)
Table S1 Sequences of forward and reverse primers used in
qRT-PCR.
(TIF)
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